Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 16/20 | 0.55 |
| ▸ | MAOA | P21397 | 13/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20809506 | 1.00 | MAOB (0.55) | MAOBMAOAHRH3 | |
| SCHEMBL30488287 | 0.86 | MAOB (0.60) | MAOBMAOAHRH3 | |
| SCHEMBL25226171 | 0.86 | MAOB (0.60) | MAOBMAOAHRH3 | |
| SCHEMBL25270899 | 0.86 | MAOB (0.60) | MAOBMAOAHRH3 | |
| SCHEMBL30488305 | 0.86 | MAOB (0.60) | MAOBMAOAHRH3 | |
| SCHEMBL25268592 | 0.85 | MAOB (0.66) | MAOBMAOAHRH3 | |
| SCHEMBL30488303 | 0.85 | MAOB (0.66) | MAOBMAOAHRH3 | |
| SCHEMBL25272329 | 0.84 | MAOB (0.57) | MAOBMAOAHRH3 | |
| SCHEMBL31185615 | 0.84 | MAOB (0.57) | MAOBMAOAHRH3 | |
| SCHEMBL25224706 | 0.84 | MAOB (0.57) | MAOBMAOAHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444697-A1 | CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | CELGENE CORPORATION (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-118632834-A | Indanyl compounds containing carboxylic acids for the treatment of neurodegenerative diseases | 细胞基因公司 | 2024-09-10 | — | — | CN | disclosed |
| WO-2023107563-A1 | CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | CELGENE CORPORATION (US) | 2023-06-15 | — | — | WO | disclosed |